Delivery Order SPE2DB20D3103-SPE2DB22FL4F0
Award Date
10/22/21
Potential Completion Date
10/25/21
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of pharmaceutical products, specifically REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, to the Defense Logistics Agency (DLA). The award, valued at $22,500.66, was granted to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a completion date of February 5, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $12,154.39 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 3, 2024 with a completion date of July 5, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, with a ceiling value of $4,410.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of the pharmaceutical product Rebif Rebidose 44 mcg/0.5 ml, a multiple sclerosis medication. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,054.32 delivery order is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a prescription medication. The contract has an ultimate completion date of April 24, 2023 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $278,847.16, is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of the pharmaceutical product REBIF 44 MCG/0.5 ML SYRINGE 0.5ML. The contract, valued at $11,550.96, is a delivery order with a firm fixed price and an ultimate completion date of August 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been...
This federal contract award, valued at $11,381.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rebif 44 mcg/0.5 mL syringes, a multiple sclerosis medication, with a completion date of May 16, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order for the pharmaceutical product Rebif Rebidose 44 mcg/0.5 ml, placed with the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,986.72, was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This federal contract award is for the delivery of Rebif 44 mcg/0.5 mL syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $127,917.04 and an ultimate completion date of July 28, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $64,142.21, is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of June 26, 2024 and is a firm fixed-price delivery order. No set-aside designation was used for this award. AmerisourceBergen holds a significant...